Learn More
Medchemexpress LLC Tasurgratinib succinate | 1879965-80-6 | 99.2% | 705.8 g/mol | C32H37N5O6.3/2C4H6O4 | 10 MG

Supplier: Medchemexpress LLC HY101466A10MG
Tasurgratinib succinate (E7090) is an orally available, selective inhibitor of fibroblast growth factor receptors FGFR1-3 used in preclinical oncology research. It potently inhibits FGFR signaling at low-nanomolar concentrations and has demonstrated antiproliferative activity in FGFR-driven cancer cell lines.
- Selective FGFR1-3 inhibition with low-nanomolar potency.
- Demonstrated antiproliferative activity in FGFR-driven cell lines.
- Supplied as the succinate salt for preclinical experiments.
- High purity suitable for biochemical and cellular assays.
- Provided in small-mass packages for research use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.